TY - JOUR
KW - buprenorphine
KW - interdisciplinary team
KW - opioid use disorder
KW - Primary Health Care
AU - Courtenay Gilmore Wilson
AU - Blake Fagan
A1 - 
AB - Office-Based Opioid Treatment (OBOT) with buprenorphine has been available since 2000; however, many barriers to OBOT within primary care exist, and only 3.6% of family medicine physicians are waivered to prescribe buprenorphine.1 We have successfully integrated OBOT into our primary care practice, expanding access to treatment for opioid use disorder.
BT - Annals of family medicine
C5 - Education & Workforce; Opioids & Substance Use
CP - 5
CY - United States
DO - 10.1370/afm.2139
IS - 5
JF - Annals of family medicine
LA - eng
M1 - Journal Article
N2 - Office-Based Opioid Treatment (OBOT) with buprenorphine has been available since 2000; however, many barriers to OBOT within primary care exist, and only 3.6% of family medicine physicians are waivered to prescribe buprenorphine.1 We have successfully integrated OBOT into our primary care practice, expanding access to treatment for opioid use disorder.
PP - United States
PY - 2017
SN - 1544-1717; 1544-1709
SP - 481
T1 - Providing Office-Based Treatment of Opioid Use Disorder
T2 - Annals of family medicine
TI - Providing Office-Based Treatment of Opioid Use Disorder
U1 - Education & Workforce; Opioids & Substance Use
U2 - 28893820
U3 - 10.1370/afm.2139
VL - 15
VO - 1544-1717; 1544-1709
Y1 - 2017
Y2 - Sep
ER -